Search
for
Sort by
Research 421–450 of 1000+
- Hair Loss in Youngsters
- Scaly Papular Lesions
- Alopecia
- USE OF SPIRONOLACTONE IN COMBINATION WITH AN ORAL CONTRACEPTIVE IN TREATMENT OF HIRSUTISM
- 13. Wound Healing & Hair
- 4. Bullous/Mucous Membrane
- Drug-induced changes in hair growth
- 1407 ANDROGENETIC ALOPECIA, PROSTATE VOLUME AND URINARY SYMPTOMS. IS THERE A RELATIONSHIP? A CASE-CONTROL STUDY
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Simultaneous Estimation of Finasteride and Tamsulosin Hydrochloride in Combined Dosage Forms by RP-HPLC-PDA Method
- Discovery of New Drug Therapies Based on the Study of Adverse Reactions
- The relation between androgenetic thin hair diagnosed by trichoscope and benign prostatic hyperplasia
- Comparative Effects of Ustekinumab and Vedolizumab on Alopecia in Ulcerative Colitis: A Systematic Review and Meta-Analysis
- Formulation and evaluation of beta-sitosterol enriched herbal scalp serum
- New onset of alopecia in a young woman with end-stage renal disease
- 187 Protective Effect of DA-9401 on Acute use of Finasteride on Sprague–Dawley Rats
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Harmless Herbs? A Review of the Recent Literature
- Neuroimmunology of Stress: Skin Takes Center Stage
- The Rotterdam Study: 2016 objectives and design update
- Polycystic Ovary Syndrome
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Root hair growth in Arabidopsis thaliana is directed by calcium and an endogenous polarity
- COVID-19 and Sex Differences
- Androgenetic alopecia: pathogenesis and potential for therapy
- K <sub>ATP</sub> Channels and Cardiovascular Disease
- Lupus erythematosus: systemic and cutaneous manifestations
- Dermatological adverse events with taxane chemotherapy